Sein CANTO (Paris) A Cohort to Quantify and to Predict Treatment Related Chronic Toxicities in Patients With Non-metastatic Breast Cancer. Paris PAUL-HENRI COTTU
Sein CirCA 01 - IC 2014-05 Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01). Paris JEAN-YVES PIERGA
VADS CA209-9T9 ProNiHN A FRENCH, PROSPECTIVE, NON-INTERVENTIONAL RESEARCH (NIR) OF NIVOLUMAB IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PROGRESSING ON OR AFTER PLATINUM-BASED THERAPY Paris CHRISTOPHE LE TOURNEAU
Gynécologie - Ovaires GREAT 1550-C081 Genomic BRCA and Extensive ovArian cancer Testing Paris, Saint-Cloud MANUEL RODRIGUES, MANUEL RODRIGUES
VADS MIBI-THYR Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (Sup or Egal to 15 mm) Classified Bethesda III or IV on Cytology. Saint-Cloud
Sein CANTO (Saint-Cloud) A Cohort to Quantify and to Predict Treatment Related Chronic Toxicities in Patients With Non-metastatic Breast Cancer Saint-Cloud FLORENCE LEREBOURS
Sein TUMOSPEC (ONCO04) - Paris Investigation of Tumour Spectrum, Penetrance and Clinical Utility of Germline Mutations in New Breast and Ovarian Cancer Susceptibility Genes. Paris, Saint-Cloud DOMINIQUE STOPPA-LYONNET, DOMINIQUE STOPPA-LYONNET
Hématologie Myélodysplasie QPL-MDS Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS) Saint-Cloud SANDRA MALAK